PODCAST · health
Evidence Based Medicine presented by InpharmD™
by InpharmD™
We take the most popularly asked clinical questions monthly and create a class around the corresponding evidence. Our EBM podcast will offer a glimpse into the evidence covered, and listeners can follow up with our CE if interested in more information.
Episodes
-
Ketamine for Sickle Cell Disease
InpharmD's EBM podcast focuses on commonly asked drug information questions and the associated literature. This episode focuses on the use of ketamine for Sickle Cell Disease.
-
Tirzepatide for Sleep Apnea
InpharmD's EBM podcast focuses on commonly asked drug information (DI) questions and the associated literature. Everyday, our queue gets tons of questions asked by health care providers all around the country. For this episode, we assess tirzepatide for obstructive sleep apnea and analyze the...
-
Excoriation Disorder
InpharmD's EBM podcast focuses on commonly asked drug information (DI) questions and the associated literature. Everyday, our queue gets tons of questions asked by health care providers all around the country. For this episode, we assess treatment options for excoriation disorder.
-
Phenytoin for Tacrolimus Toxicity
InpharmD's EBM podcast focuses on commonly asked DI questions. Every day, our queue gets tons of new questions asked from providers all around the country. Today's podcast focuses on the use of phenytoin to treat tacrolimus toxicity.
-
Atypical Antipsychotics and QT–prolongation
InpharmD's EBM podcast focuses on commonly asked drug information questions. Every day, our queue gets tons of new questions asked from providers all around the country. One question that's been garnering a lot of views from our users right now is which atypical antipsychotics are associated with...
-
Apixaban in Peripheral Artery Disease
Join InpharmD as we discuss the role of apixaban in peripheral artery disease.
-
Safety and Efficacy of RSV Vaccines
Join InpharmD as we discuss the safety and efficacy of two FDA-approved RSV vaccines, Arexvy and Abrysvo.
-
Safety and Efficacy of Rezafungin
Join us as we discuss the data surrounding newly approved antifungal agent, rezafungin. Interested in learning more? Join our CE on rezafungin on July 27th at 12:00 PM EST - open to all pharmacists!
-
Perioperative Duloxetine During Orthopedic Surgery for Pain Reduction
Join InpharmD as we discuss the data on perioperative duloxetine (Cymbalta) during orthopedic surgery for pain reduction. Interested in the full data response? Read here!
-
Lecanemab in the treatment of Alzheimer's Dementia
Every month, InpharmD creates a continuing-education (CE) class on the most commonly asked drug information question and the related evidence. Our podcast offers a sneak peak into our CE as we briefly discuss the topic. Episode-2 looks at the safety and efficacy of lecanemab in the treatment of...
-
Tirzepatide for Weight Loss in Diabetic Patients
Join us as we discuss the evidence surrounding tirzepatide for weight loss in diabetic patient populations.
-
Yet Another Drug Shortage? Alternatives to Oxytocin
Many hospitals have been dealing with the recent oxytocin shortage. With this episode, we discuss possible alternatives and adjuncts to oxytocin, based on the evidence available.
-
Can Evusheld Increase Cardiovascular Events?
Tune in as we discuss the PROVENT trial and the on-going TACKLE trial to determine whether or not Evusheld can increase cardiovascular events.
-
Could Intermittent Fasting be the Next Big Weight Loss Tool?
A randomized clinical trial conducted to assess time-restricted eating with calorie restriction as compared with daily calorie restriction alone for the effects on weight loss and metabolic risk factors in obese patients.
-
A 4th Dose of the COVID-19 Vaccine
A regression analysis conducted in Israel showed that a fourth dose appeared to increase the protection against severe illness relative to three doses that were administered more than 4 months earlier. Further studies are needed before applying this to a larger population.
-
A Possible Alternative for Recurrent Urinary Tract Infections
A multicenter, randomized, open label, non-inferiority trial conducted to test and compare the efficacy of methenamine hippurate for prevention of recurrent urinary tract infections (UTI) with the current standard prophylaxis of daily low dose antibiotics.
-
Estimation of Breast Cancer Overdiagnosis
A cohort study conducted to estimate the rate of breast cancer overdiagnosis in contemporary mammography practice accounting for the detection of nonprogressive cancer.
-
Can Ketamine Treat Acute, Severe Suicidal Ideation?
A prospective, double blind, superiority, randomized placebo-controlled trial conducted to confirm the rapid onset anti-suicidal benefits of ketamine in the short term and at six weeks.
-
Could SER-109 be an Answer for Recurrent C.Difficile Infection?
A phase 3, double-blind, randomized, placebo-controlled trial conducted to show superiority of SER-109 in reducing the risk of C. difficile infection recurrence up to 8 weeks after treatment.
-
To Boost or not to Boost - That is the Question
A retrospective study conducted to assess for any decrease in mortality associated with the use of the BNT162b2 (BioNTech, Pfizer vaccine) booster.
-
Old Dogs Can Learn New Tricks: Is Outpatient Remdesivir a Game Changer against Omicron?
A double-blind, randomized, placebo-controlled trial conducted to evaluate the efficacy and safety of a 3-day course of remdesivir in high-risk, non-hospitalized patients with COVID-19.
-
Can Financial Incentives Help Pregnant Patients Quit Smoking?
A single-blind, multicenter, randomized, controlled trial conducted to evaluate the efficacy of financial incentives dependent on continuous smoking abstinence on smoking cessation and birth outcomes among pregnant smokers.
-
Milvexian for the Prevention of Venous Thromboembolism
An open-label, randomized, parallel-group, adaptive design with blinded outcome adjudication trial conducted to compare the efficacy and safety of milvexian and enoxaparin in patients undergoing elective knee arthroplasty.
-
Merck's New COVID-19 Pill - Molnupiravir
The first in-human, phase 1, randomized, double-blind, placebo-controlled study conducted to determine the safety, tolerability, and pharmacokinetics of single and multiple ascending oral doses of molnupiravir in healthy subjects.
-
Can chlorthalidone therapy improve blood-pressure control in patients with advanced CKD?
A double-blind, randomized, placebo-controlled trial conducted to assess the role of chlorthalidone for hypertension in advanced chronic kidney disease.
-
Does the Addition of Vasopressin and Methylprednisolone Improve Outcomes in Patients with In-Hospital Cardiac Arrest?
An investigator-initiated, multi-center, randomized, double-blind, superiority, placebo-controlled conducted to determine whether the combination of vasopressin and methylprednisolone administered during in-hospital cardiac arrest improves return of spontaneous circulation.
-
Can fluvoxamine prevent COVID-19 related hospitalization?
A randomized, adaptive, platform trial conducted to assess the efficacy of fluvoxamine versus placebo in preventing hospitalization (defined as either retention in a COVID-19 emergency setting or transfer to a tertiary hospital due to COVID-19).
-
Can MDMA Treat Post-Traumatic Stress Disorder?
A randomized, double-blind, placebo-controlled, phase 3 study, conducted to evaluate the efficacy and safety MDMA-assisted therapy for PTSD compared with placebo with therapy?
-
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
A randomized, double-blind, parallel-group, placebo-controlled, event-driven trial conducted to evaluate the effects of SGLT2 inhibition with empagliflozin on major heart failure outcomes in patients with heart failure and a preserved ejection fraction.
-
Functional Neurological Disorder after COVID-19 Vaccination
This week, InpharmD looks at two case reports discussing presentations of patients who developed Functional Neurological Disorder (FND) after receiving COVID-19 vaccination.
-
Myocarditis after COVID-19 Vaccination
This week, we look at two different case reports: 1) Patients With Acute Myocarditis Following mRNA COVID-19 Vaccination 2) Symptomatic Acute Myocarditis in 7 Adolescents After Pfizer-BioNTech COVID-19 Vaccination Tune in to learn more!
-
World Trade Center Dust Exposure and Hepatic Steatosis
A cohort study conducted to determine whether there is a dose–response relationship between the intensity of exposure to the World Trade Center (WTC) site and the risk of hepatic steatosis (HS) in the WTC General Responder Cohort (GRC).
-
Processed Foods and the Risk of Inflammatory Bowel Disease
A prospective, multi-center, international cohort study conducted to evaluate the relation between intake of ultra-processed food and risk of inflammatory bowel disease (IBD), Crohn's Disease, and Ulcerative Colitis.
-
Childhood Trauma and Rewarding Effects of Morphine
A double-blind, placebo-controlled, cross-over study conducted to assess the impact of childhood trauma on responses to morphine and pain processing.
-
Can a Cup of Coffee Keep the Cardiologist Away?
A study that use supervised machine learning to identify potential variables important to assessing risk of incident chronic heart disease (CHD), stroke, and heart failure (HF) in a hypothesis-free, data-driven manner.
-
An Intra-Oral Device for Weight Loss
A study conducted to investigate the acceptability and tolerability of an intra-oral device, designed to facilitate weight loss
-
Curious Cases of Mucormycosis
Here we provide an overview of three case reports focusing on patients who developed rhino-orbital mucormycosis, a rare fungal infection, potentially from COVID-19.
-
Continuous Glucose Monitoring in Patients With Type-2 Diabetes Receiving Basal Insulin
A multicenter, randomized, open-label, parallel-group trial conducted to determine the effectiveness of continuous glucose monitoring (CGM) in adults with type 2 diabetes treated with basal insulin.
-
Once-Weekly Semaglutide in Adults with Overweight or Obesity
An international, randomized, double-blind, placebo-controlled trial conducted to evaluate the efficacy and safety of semaglutide, as compared with placebo, as an adjunct to lifestyle intervention for reducing body weight in overweight and obese adults without diabetes.
-
Effect of Continuous Infusion of Hypertonic Saline vs Standard Care on 6-Month Neurological Outcomes in Patients With Traumatic Brain Injury
An investigator-initiated, multicenter, parallel-group, open-label, randomized clinical trial conducted to determine whether continuous infusion of hypertonic saline solution improves neurological outcomes at 6 months in patients with traumatic brain injury
-
Sacituzumab Govitecan (Trodelvy) in Metastatic Triple-Negative Breast Cancer
A global, phase-3 trial conducted to evaluate the efficacy and safety of sacituzumab govitecan (Trodelvy) as compared with single-agent chemotherapy of the physician's choice in patients with relapsed or refractory metastatic triple-negative breast cancer. This trial led to the FDA's accelerated...
-
Dexmedetomidine or Propofol for Sedation in Mechanically Ventilated Adults with Sepsis
A mutlicenter, randomized trial conducted to test whether dexmedetomidine leads to better short-term and long-term outcomes than propofol in mechanically ventilated adults with sepsis.
-
The MIDAS Trial: Effect of midodrine versus placebo on time to vasopressor discontinuation in patients with persistent hypotension in the intensive care unit
A randomized, multicenter, international, double-blind, placebo-controlled trial conducted to determine whether the addition of midodrine to standard care reduces the time to discontinuation of IV vasopressor use in otherwise resuscitated patients
-
Post-Covid Syndrome and Rates of Organ Dysfunction
A retrospective, multicenter, observational, database analysis conducted to quantify rates of organ-specific dysfunction in individuals with COVID-19 after discharge from hospital compared with a matched control group from the general population
-
Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation for COVID-19 Patients
A randomized, open-label, trial conducted to evaluate the effects of intermediate-dose vs standard-dose prophylactic anticoagulation among patients with COVID-19 admitted to the intensive care unit (ICU).
-
Acute Kidney Injury in COVID-19 Patients After Hospital Discharge
A retrospective, observational, cohort study conducted to compare the rate of change in estimated glomerular filtration rate (eGFR) after hospital discharge between patients with and without COVID-19 who experienced in-hospital acute kidney injury (AKI)
-
Effect of Bamlanivimab as Monotherapy or in Combination with Etesevimab on Patients with COVID-19
A randomized study conducted to determine the effect of bamlanivimab monotherapy and combination therapy with bamlanivimab and etesevimab on severe acute respiratory syndrome coronavirus 2(SARS-CoV-2) viral load in mild to moderate COVID-19
-
Dexamethasone in Hospitalized Patients with COVID-19
A controlled, open-label trial conducted to report the results of the controlled, open-label Randomized Evaluation of COVID-19 Therapy (RECOVERY) trial of dexamethasone in patients hospitalized with COVID-19.
-
Vitamin-D3 Supplementation and COVID-19
A randomized multicenter, double-blind, parallel-group, placebo-controlled trial, conducted to investigate the effect of vitamin D3 administration on hospital length of stay and other relevant clinical outcomes and adverse events in hospitalized patients with moderate to severe COVID-19.
-
Effect of Zinc and Vitamin-C on Ambulatory Patients with COVID-19
A randomized, multi-center, open-label, open-label, factorial clinical trial conducted to examine whether high-dose zinc and/or high-dose ascorbic acid reduce the severity or duration of symptoms compared with usual care among ambulatory patients with SARS-CoV-2 infection.
We're indexing this podcast's transcripts for the first time — this can take a minute or two. We'll show results as soon as they're ready.
No matches for "" in this podcast's transcripts.
No topics indexed yet for this podcast.
Loading reviews...
ABOUT THIS SHOW
We take the most popularly asked clinical questions monthly and create a class around the corresponding evidence. Our EBM podcast will offer a glimpse into the evidence covered, and listeners can follow up with our CE if interested in more information.
HOSTED BY
InpharmD™
Loading similar podcasts...
Frequently Asked Questions
How many episodes does Evidence Based Medicine presented by InpharmD™ have?
Evidence Based Medicine presented by InpharmD™ currently has 78 episodes available on PodParley. New episodes are automatically indexed when they're published to the podcast feed.
What is Evidence Based Medicine presented by InpharmD™ about?
We take the most popularly asked clinical questions monthly and create a class around the corresponding evidence. Our EBM podcast will offer a glimpse into the evidence covered, and listeners can follow up with our CE if interested in more information.
How often does Evidence Based Medicine presented by InpharmD™ release new episodes?
Evidence Based Medicine presented by InpharmD™ has 78 episodes. Check the episode list to see recent publication dates and frequency.
Where can I listen to Evidence Based Medicine presented by InpharmD™?
You can listen to Evidence Based Medicine presented by InpharmD™ on PodParley by clicking any episode. We provide an embedded audio player for direct listening, and you can also subscribe via your preferred podcast app using the RSS feed.
Who hosts Evidence Based Medicine presented by InpharmD™?
Evidence Based Medicine presented by InpharmD™ is created and hosted by InpharmD™.
URL copied to clipboard!